Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Molecular Cancer Therapeutics|December 17, 2002
Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiationCarmelo Blanquicett, G Yancey Gillespie, L Burt Nabors, et al.Cancer Journal (Sudbury, Mass.)|September 1, 2007
Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylaseMuhammad Wasif Saif, Glenda Black, Shalija Roy, et al.Cancer Research|September 1, 2016
Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD PromoterRentian Wu, Qian Nie, Erin E Tapper, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcomeM Wasif Saif, Mohammaed A Eloubeidi, Suzanne Russo, et al.Journal of the National Cancer Institute|November 9, 2014
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)Adam M Lee, Qian Shi, Emily Pavey, et al.British Journal of Clinical Pharmacology|January 25, 2021
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicitySeid Hamzic, Dominic Schärer, Steven M Offer, et al.Mayo Clinic Proceedings|December 3, 2010
The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resectionHarry H Yoon, Maliha Khan, Qian Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancerNeal J Meropol, Philip J Gold, Robert B Diasio, et al.Cancer|October 24, 2013
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinomaHarry H Yoon, William R Sukov, Qian Shi, et al.Analytical Biochemistry|January 30, 2002
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitroC Ryan Miller, Allen N Gustin, Donald J Buchsbaum, et al.Pageof 9